Regenerative Medicine: Analysis, Forecast and Regulatory Requirements

Main Article Content

M P. Venkatesh
A. Akil
V Balamuralidhara
T M Pramod Kumar


Regenerative medicine is a new and expanding field in biomedical research. Organ and tissue loss through disease and injury, propel the development of a treatment that can regenerate tissue and help for less relaying in organ transplantation. Regenerative medicine has the potential to heal tissue and damaged organ. Currently, a patient suffering from diseased and injured organs can be treated with transplantation organs, but there is a shortage of donor organs. Dermatology is estimated to have a larger share in the market for regenerative medicine as skin being an organ with great cell replicate characteristics. US and Japan play a major role in the market for regenerative medicine. Food and drug administration (FDA) regulations for a medical device used in regenerative medicine are covered here to support risk-based, flexible regulatory methods to help and support the potential to bring novel treatment possibilities to market further. But due to incorrect FDA regulations, it stands as a barrier for the marketing regenerative medicines. Better and clear guidance development or a clear regulatory framework for both regenerative medicine and medical device can leads the product a best fit clinical development and product access in the market.


Download data is not yet available.

Article Details

How to Cite
Venkatesh MP, Akil A, Balamuralidhara V, Kumar TMP. Regenerative Medicine: Analysis, Forecast and Regulatory Requirements. ijpqa [Internet]. 2020 May 15 [cited 2021 Aug. 1];11(03):350-4. Available from:
Review Article